MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in ...

The APPLAUSE-IgAN results demonstrate that targeted, disease-modifying therapy can preserve long-term kidney function.

MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe TGFR will be available for sa ...

Investigators assessed markers of chronic kidney disease (CKD) with cancer risks using data from more than one million patients.

A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.

Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.

BIC/TAF/FTC demonstrated a stronger long-term immunologic response than DTG/TDF/FTC in patients with HIV who had low CD4+ ...